Proliferation Saturation Index to Simulate Adaptive Radiation Fractionation in HPV-Associated Oropharyngeal Cancer
Mohammad U. Zahid(The University of Texas MD Anderson Cancer Center), Heiko Enderling(The University of Texas MD Anderson Cancer Center), Michelle Echevarria(Moffitt Cancer Center), G.Q. Yang(Moffitt Cancer Center), J.J. Caudell(Moffitt Cancer Center)
International Journal of Radiation Oncology*Biology*Physics
September 29, 2023
Cited by 2
Related Papers
Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck: ASCO Guideline
|Journal of Clinical Oncology|2020|221
Classical mathematical models for prediction of response to chemotherapy and immunotherapy
|PLoS Computational Biology|2022|98
Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer
|International Journal of Radiation Oncology*Biology*Physics|2023|18
A phase II, randomized study of nivolumab (NIVO) and Ipilimumab (IPI) versus NIVO, IPI and stereotactic body radiation therapy (SBRT) for metastatic Merkel cell carcinoma (MCC, NCT03071406): A preliminary report
|Annals of Oncology|2019|5
NBTXR3 Radiation Enhancing Hafnium Oxide Nanoparticles Activated By Radiotherapy In Combination With Anti-PD-1 Therapy: A Phase I Study
|International Journal of Radiation Oncology*Biology*Physics|2020|4